Garsorasib
Modify Date: 2024-01-14 11:43:33
Garsorasib structure
|
Common Name | Garsorasib | ||
|---|---|---|---|---|
| CAS Number | 2559761-14-5 | Molecular Weight | 598.65 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C32H32F2N8O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GarsorasibGarsorasib is a potent inhibitor of KRAS G12C with an IC50 of 10 nM. Garsorasib has the potential for the research of various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (non-small cell lung cancer) (extracted from patent WO2020233592A1, compound 2)[1]. |
| Name | Garsorasib |
|---|
| Description | Garsorasib is a potent inhibitor of KRAS G12C with an IC50 of 10 nM. Garsorasib has the potential for the research of various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (non-small cell lung cancer) (extracted from patent WO2020233592A1, compound 2)[1]. |
|---|---|
| Related Catalog | |
| Target |
KRas G12C |
| References |
[1]. Wang, Lisha, et al. Cbp/ep300 inhibitor and use thereof. Patent WO2021213521A1. |
| Molecular Formula | C32H32F2N8O2 |
|---|---|
| Molecular Weight | 598.65 |